Alcoa Corporation (AA) Looks Good: Stock Adds 6.8% in Session

In this article:

Alcoa Corporation AA was a big mover last session, as the company saw its shares rise more than 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $44.34 to $50.62 in the past one-month time frame.

The stock was driven after U.S. sanctions were implemented against a Russian manufacturer of aluminum.

The company has seen one positive estimate revision in the past month, while its Zacks Consensus Estimate has also moved higher over the same time period, suggesting that more solid trading could be ahead for Alcoa. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Alcoa Corporation currently has a Zacks Rank #3 (Hold), while its Earnings ESP is positive.

Alcoa Corp. Price

Alcoa Corp. Price | Alcoa Corp. Quote

Investors interested in the Industrial Products sector may consider Axon Enterprise, Inc. AAXN, which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is AA going up? Or down? Predict to see what others think: Up or Down

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Alcoa Corp. (AA) : Free Stock Analysis Report
 
Axon Enterprise, Inc (AAXN) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Advertisement